Global Health Ltd (MEDANTA)
🎯 Key Takeaways
- Revenue grew 12.5% QoQ to ₹1,304 in Q1FY27.
- Market Cap
- ₹36,689
- P/E Ratio
- 65.9
- P/B Ratio
- 9.26
- ROE
- 14.0%
- ROCE
- 15.8%
- Debt/Equity
- 0.30
- Promoter
- 33.0%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 1,099 | 1,121 | 1,159 | 1,304 |
| Operating Profit | 181 | 156 | 177 | 218 |
| OPM % | 16.5% | 13.9% | 15.3% | 16.7% |
| Net Profit | 158 | 95 | 142 | 157 |
| EPS | ₹5.89 | ₹3.54 | ₹5.36 | ₹5.91 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 54 | 54 | 54 | 54 |
| Reserves | 3,333 | 3,088 | 3,908 | 3,654 |
| Borrowings | 328 | 688 | 1,190 | 945 |
| Total Liabilities | 4,766 | 4,510 | 5,905 | 5,410 |
| Fixed Assets | 2,519 | 2,455 | 3,779 | 3,184 |
| Investments | 3 | 3 | 3 | 3 |
| Total Assets | 4,766 | 4,510 | 5,905 | 5,410 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +624 |
| Investing | -721 |
| Financing | -97 |
| Net Cash Flow | -194 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 33.0% | 33.0% | 33.0% | 33.0% |
| FII | 11.4% | 10.5% | 10.2% | 9.5% |
| DII | 13.0% | 14.0% | 14.8% | 16.9% |
| Public | 6.0% | 6.0% | 5.9% | 5.6% |
| # Shareholders | 1,55,806 | 1,51,241 | 1,47,390 | 1,40,531 |
⚖️ Peer Comparison — Healthcare
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| APOLLOHOSP | 1.17 L Cr | 56.0 | 22.1% | — | 0.60 |
| MANIPALHOS | 93,221 | — | — | — | 1.25 |
| MAXHEALTH | 90,482 | 62.0 | 14.4% | — | 0.27 |
| ASTERDM | 60,634 | 112.6 | 12.9% | — | 0.17 |
| FORTIS | 57,996 | 55.4 | 13.3% | — | 0.29 |
| MEDANTA | 36,689 | 65.9 | 21.9% | — | 0.10 |
| NH | 36,640 | 44.6 | 13.7% | — | 1.07 |
| LALPATHLAB | 33,320 | 47.9 | 29.6% | — | 0.00 |
| KIMS | 31,423 | 146.7 | 9.7% | — | 1.44 |
| POLYMED | 16,977 | 53.9 | 15.1% | — | 0.06 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🟡 Board Meeting2026-09-29Global Health Limited announced on September 29, 2026 that it acquired a 10,560 sq. metre land parcel in Ghaziabad, Uttar Pradesh, for approximately ₹…
- 🟡 Board Meeting2026-09-28Global Health Limited announced it received a 10560.36 sq. meter land parcel from UP Housing & Development Board for Rs 165.82 crores in Ghaziabad to …
- Announcement2026-09-24Global Health Limited announced that its trading window for share transactions will close on October 1, 2026, remaining shut until 48 hours after the …
- 🔴 Corporate Action2026-09-22Global Health Limited announced the allotment of 3,000 equity shares of Rs. 2 face value at a premium of Rs. 1,498 per share to the GHL Employees Welf…
- 🔴 Announcement2026-09-22Global Health Limited announced its schedule for analyst and institutional investor meetings on September 25, 2026, including a one-on-one virtual ses…
- 🔴 Announcement2026-09-17Global Health Limited announced its upcoming investor and analyst meeting schedule on September 17, 2026, with one-on-one sessions planned with USS In…
- 🟡 voting results2026-09-16At the 22nd Annual General Meeting held on September 16, 2026 via video conference, shareholders approved all four resolutions including audited finan…
- 🟡 Board Meeting2026-09-16Global Health Limited held its 22nd Annual General Meeting on September 16, 2026 via video conferencing, with shareholders voting electronically. Chai…
- 🔴 Announcement2026-09-11Global Health Limited announced its upcoming investor and analyst meeting schedule for September 2026, including sessions with Jefferies India on Sept…
- 🔴 Announcement2026-09-11Global Health Limited announced its upcoming investor and analyst meeting schedule for September 2026, including sessions with Jefferies India on Sept…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when MEDANTA files new disclosures
Track MEDANTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MEDANTA — FreeFree account · 2 AI queries/day